aTyr Pharma, Inc. (ATYR) Tops Q1 EPS by 2c

aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Exchange Bank declares Q3 dividend, CEO to retire in 2027
• Gordon Haskett cuts Walmart rating to Accumulate with $110 target